Related articles

KRAS

Gene and mutation driving aggressive growth in pancreatic and other tumors; target of daraxonrasib and divarasib.

• Oncologists in Chicago and Madrid Erupt in Standing Ovations for Breakthroughs Against Pancreatic and Lung Cancer